194 related articles for article (PubMed ID: 34770845)
21. Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002.
Jacobs MD; Black J; Futer O; Swenson L; Hare B; Fleming M; Saxena K
J Biol Chem; 2005 Apr; 280(14):13728-34. PubMed ID: 15657054
[TBL] [Abstract][Full Text] [Related]
22. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Pim2-prolonged skin allograft survival through the apoptosis regulation pathway.
Liu H; Zhang C; Liang T; Song J; Hao J; Hou G
Cell Mol Immunol; 2012 Nov; 9(6):503-10. PubMed ID: 23085945
[TBL] [Abstract][Full Text] [Related]
24. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression.
Kronschnabl P; Grünweller A; Hartmann RK; Aigner A; Weirauch U
Int J Oncol; 2020 Feb; 56(2):448-459. PubMed ID: 31894300
[TBL] [Abstract][Full Text] [Related]
26. Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes.
Poungpair O; Chaicumpa W; Kulkeaw K; Maneewatch S; Thueng-in K; Srimanote P; Tongtawe P; Songserm T; Lekcharoensuk P; Tapchaisri P
J Virol Methods; 2009 Jul; 159(1):105-11. PubMed ID: 19442853
[TBL] [Abstract][Full Text] [Related]
27. Control of Pim2 kinase stability and expression in transformed human haematopoietic cells.
Adam K; Lambert M; Lestang E; Champenois G; Dusanter-Fourt I; Tamburini J; Bouscary D; Lacombe C; Zermati Y; Mayeux P
Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26500282
[TBL] [Abstract][Full Text] [Related]
28. PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma.
Gómez-Abad C; Pisonero H; Blanco-Aparicio C; Roncador G; González-Menchén A; Martinez-Climent JA; Mata E; Rodríguez ME; Muñoz-González G; Sánchez-Beato M; Leal JF; Bischoff JR; Piris MA
Blood; 2011 Nov; 118(20):5517-27. PubMed ID: 21937691
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase PIM2: A simple PIM family kinase with complex functions in cancer metabolism and therapeutics.
Wang Y; Xiu J; Ren C; Yu Z
J Cancer; 2021; 12(9):2570-2581. PubMed ID: 33854618
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and evaluation of non-ATP-competitive small-molecule Polo-like kinase 1 (Plk1) inhibitors.
Chen DX; Huang J; Liu M; Xu YG; Jiang C
Arch Pharm (Weinheim); 2015 Jan; 348(1):2-9. PubMed ID: 25430493
[TBL] [Abstract][Full Text] [Related]
31. Molecular and enzoinformatics perspectives of targeting Polo-like kinase 1 in cancer therapy.
Shakil S; Baig MH; Tabrez S; Rizvi SMD; Zaidi SK; Ashraf GM; Ansari SA; Khan AAP; Al-Qahtani MH; Abuzenadah AM; Chaudhary AG
Semin Cancer Biol; 2019 Jun; 56():47-55. PubMed ID: 29122685
[TBL] [Abstract][Full Text] [Related]
32. Production of Recombinant Human scFv Against Tetanus Toxin Heavy Chain by Phage Display Technology.
Khalili E; Lakzaei M; Rasaee MJ; Aminian M
Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):303-9. PubMed ID: 26492617
[TBL] [Abstract][Full Text] [Related]
33. Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma.
Yang Q; Chen LS; Neelapu SS; Miranda RN; Medeiros LJ; Gandhi V
Blood; 2012 Oct; 120(17):3491-500. PubMed ID: 22955922
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.
Li YY; Mukaida N
World J Gastroenterol; 2014 Jul; 20(28):9392-404. PubMed ID: 25071334
[TBL] [Abstract][Full Text] [Related]
35. Human transbodies to VP40 inhibit cellular egress of Ebola virus-like particles.
Teimoori S; Seesuay W; Jittavisutthikul S; Chaisri U; Sookrung N; Densumite J; Saelim N; Chulanetra M; Maneewatch S; Chaicumpa W
Biochem Biophys Res Commun; 2016 Oct; 479(2):245-252. PubMed ID: 27638305
[TBL] [Abstract][Full Text] [Related]
36. Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors.
Wurz RP; Sastri C; D'Amico DC; Herberich B; Jackson CLM; Pettus LH; Tasker AS; Wu B; Guerrero N; Lipford JR; Winston JT; Yang Y; Wang P; Nguyen Y; Andrews KL; Huang X; Lee MR; Mohr C; Zhang JD; Reid DL; Xu Y; Zhou Y; Wang HL
Bioorg Med Chem Lett; 2016 Nov; 26(22):5580-5590. PubMed ID: 27769621
[TBL] [Abstract][Full Text] [Related]
37. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z
Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266
[No Abstract] [Full Text] [Related]
38. Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies.
Burger MT; Nishiguchi G; Han W; Lan J; Simmons R; Atallah G; Ding Y; Tamez V; Zhang Y; Mathur M; Muller K; Bellamacina C; Lindvall MK; Zang R; Huh K; Feucht P; Zavorotinskaya T; Dai Y; Basham S; Chan J; Ginn E; Aycinena A; Holash J; Castillo J; Langowski JL; Wang Y; Chen MY; Lambert A; Fritsch C; Kauffmann A; Pfister E; Vanasse KG; Garcia PD
J Med Chem; 2015 Nov; 58(21):8373-86. PubMed ID: 26505898
[TBL] [Abstract][Full Text] [Related]
39. New potent and selective inhibitor of Pim-1/3 protein kinases sensitizes human colon carcinoma cells to doxorubicin.
Moreau P; Dezhenkova LG; Anizon F; Nauton L; Thery V; Liang S; Kaluzhny DN; Shtil AA
Anticancer Agents Med Chem; 2014; 14(9):1228-36. PubMed ID: 25175798
[TBL] [Abstract][Full Text] [Related]
40. Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle.
Poungpair O; Bangphoomi K; Chaowalit P; Sawasdee N; Saokaew N; Choowongkomon K; Chaicumpa W; Yenchitsomanus PT
MAbs; 2014; 6(2):474-82. PubMed ID: 24492300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]